Sirturo (Bedaquline) 100 MG tablets 188/BT

The Florida Department of Health (FDOH), Division of Disease Control and Health Protection, is seeking to procure Sirturo (Bedaquline) 100 MG tablets 188/BT, a medication used to treat specific multi-drug resistant strains of tuberculosis, through a single-source acquisition from Cardinal Health dba Metro Medical. The estimated value of this procurement is $136,000.00, and the contract term is 1 year. The FDOH intends to prescribe and dispense this medication through the State Tuberculosis Medical Director and the State Pharmacy, respectively. The justification for the single-source procurement is that Sirturo (Bedaquline) 100 MG tablets 188/BT is the only medication used to treat the specific multi-drug resistant strains of tuberculosis, and Metro Medical is the only known wholesale distributor of this medication. The posting period for this opportunity will remain active for at least 15 business days, with the last day for receipt of information being August 08, 2024.

There are no set-aside designations or restrictions on the types of organizations that can respond to this opportunity. The incumbent vendor is Cardinal Health dba Metro Medical, as they are the sole distributor of the required medication. No additional information is provided regarding existing infrastructure or technology integration requirements. The budget for this procurement is $136,000.00.